Patents by Inventor Stephane Paul
Stephane Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9560109Abstract: A message management facility is described herein that is hosted by a networked node, in a process control network environment, that is separate from a control processor. The message management facility routes a stream of messages received from the control processor to a set of destinations on a supervisory network. By interposing the message management facility on a node that is interposed, in a message steam, between alarm message sources (control processors) and alarm message sinks (workstations, printers, historians), a number of additional functions can be implemented to carry out a number of advanced functions.Type: GrantFiled: July 1, 2013Date of Patent: January 31, 2017Assignee: Invensys Systems, Inc.Inventors: Irvine William Wilson, Markus Stephan Paul, Ewald Gerhard Weiss
-
Patent number: 9123584Abstract: A metrology system for gauging and spatially mapping a semiconductor material on a substrate can be used in controlling deposition and thermal activation processes.Type: GrantFiled: November 5, 2013Date of Patent: September 1, 2015Assignee: FIRST SOLAR, INCInventors: Arnold Allenic, Stephan Paul George, II, Sreenivas Jayaraman, Oleh Petro Karpenko, Chong Lim
-
Publication number: 20140065731Abstract: A metrology system for gauging and spatially mapping a semiconductor material on a substrate can be used in controlling deposition and thermal activation processes.Type: ApplicationFiled: November 5, 2013Publication date: March 6, 2014Applicant: FIRST SOLAR, INCInventors: Arnold Allenic, Stephan Paul George, II, Sreenivas Jayaraman, Oleh Petro Karpenko, Chong Lim
-
Patent number: 8603839Abstract: A metrology system for gauging and spatially mapping a semiconductor material on a substrate can be used in controlling deposition and thermal activation processes.Type: GrantFiled: July 25, 2011Date of Patent: December 10, 2013Assignee: First Solar, Inc.Inventors: Arnold Allenic, Stephan Paul George, II, Sreenivas Jayaraman, Oleh Karpenko, Chong Lim
-
Publication number: 20130297748Abstract: A message management facility is described herein that is hosted by a networked node, in a process control network environment, that is separate from a control processor. The message management facility routes a stream of messages received from the control processor to a set of destinations on a supervisory network. By interposing the message management facility on a node that is interposed, in a message steam, between alarm message sources (control processors) and alarm message sinks (workstations, printers, historians), a number of additional functions can be implemented to carry out a number of advanced functions.Type: ApplicationFiled: July 1, 2013Publication date: November 7, 2013Inventors: Irvine William Wilson, Markus Stephan Paul, Ewald Gerhard Weiss
-
Patent number: 8449535Abstract: A system and method for assessing a degree of coupling between an electrode and tissue in a body is provided. Values for first and second components of a complex impedance (e.g., resistance and reactance or impedance magnitude and phase angle) between the electrode and the tissue are obtained. From these values, a coupling index is calculated that is indicative of a degree of coupling between the electrode and the tissue. The coupling index may be displayed to a clinician in a variety of ways to indicate the degree of coupling to the clinician. The system and method find particular application in ablation of tissue by permitting a clinician to create lesions in the tissue more effectively and safely.Type: GrantFiled: October 17, 2008Date of Patent: May 28, 2013Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.Inventors: Don Curtis Deno, Stephan Paul Miller, Saurav Paul
-
Publication number: 20120021539Abstract: A metrology system for gauging and spatially mapping a semiconductor material on a substrate can be used in controlling deposition and thermal activation processes.Type: ApplicationFiled: July 25, 2011Publication date: January 26, 2012Inventors: Arnold Allenic, Stephan Paul George, II, Sreenivas Jayaraman, Oleh Karpenko, Chong Lim
-
Patent number: 7947288Abstract: The present invention relates to a novel fusion protein with the formula X-Y, or Y-X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.Type: GrantFiled: April 27, 2009Date of Patent: May 24, 2011Assignee: Transgene S.A.Inventor: Stephane Paul
-
Patent number: 7809523Abstract: A method and apparatus for measuring a surface using a surface sensing device mounted on a scanning head on a member of a coordinate positioning apparatus. The coordinate positioning apparatus may be operated to produce relative movement between the scanning head and the surface profile and the scanning head includes a drive for producing rotational movement of the surface sensing probe about one or more axis. A desired measurement profile on the surface which the surface sensing device will track and the desired motion of the orientation of the surface sensing device as the surface' sensing device follows the measurement profile are defined. This data is used to derive the required path of the relative motion between the member of the coordinate positioning apparatus and the surface, such that the surface sensing device prescribes a trajectory along the measurement profile.Type: GrantFiled: March 23, 2007Date of Patent: October 5, 2010Assignee: Renishaw PLCInventors: Stephan Paul Hunter, Geoffrey McFarland, Kevyn Barry Jonas, Khaled Mamour
-
Publication number: 20100129403Abstract: The present invention concerns new recombinant viral vaccines. In particular the present invention provides combination products that comprise recombinant viral vectors and specific compounds able to improve the immune response raised in vivo by said recombinant viral vectors.Type: ApplicationFiled: June 15, 2007Publication date: May 27, 2010Applicant: Transgene S.A.Inventors: Jean-Yves Bonnefoy, Stephane Paul
-
Publication number: 20100074869Abstract: The present invention relates to a novel fusion protein with the formula X-Y, or Y-X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.Type: ApplicationFiled: September 15, 2009Publication date: March 25, 2010Applicant: Transgene, S.A.Inventor: Stephane Paul
-
Publication number: 20090223094Abstract: The field of the present invention provides for a large automobile that has already been adapted for snow plowing, but having the snow plow removed is then has a folding backhoe apparatus attached to the snow plow attachment points. In a preferred aspect an adapter plate is use and the end of the backhoe can either have a forward or reverse position backhoe shovel (or bucket) attached or have an adapter apparatus that can accept different utility tips such as a post digger drill, a jack hammer or a rake. In a further aspect, snow plow attachment points are attached to an adapter mechanism that can be attached to either a single arm backhoe or a double arm backhoe apparatus.Type: ApplicationFiled: March 6, 2009Publication date: September 10, 2009Inventor: Stephan Paul Boyer
-
Patent number: 7534585Abstract: The present invention relates to a novel fusion protein with the formula X—Y, or Y—X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.Type: GrantFiled: July 20, 2004Date of Patent: May 19, 2009Assignee: Transgene S.A.Inventor: Stephane Paul
-
Patent number: 7348014Abstract: The present invention concerns a poxviral particle having a targeted infection specificity conferred by an heterologous ligand moiety present at the surface of said poxviral particle and capable of specifically recognizing and binding to an anti-ligand molecule localized at the surface of target cells. The present invention further relates to a vector comprising a nucleotide sequence encoding a chimeric polypeptide including such an heterologous ligand moiety and all or part of a natural poxviral surface polypeptide. The present invention additionally concerns compositions comprising said poxviral particle or said vector as well as their use for therapeutic and prophylactic purposes. The invention is of very special interest in gene therapy applications, in particular in preventing or treating cancer in mammals.Type: GrantFiled: September 7, 2004Date of Patent: March 25, 2008Assignee: Transgene, S.A.Inventors: Jean Marc Balloul, Stephane Paul, Michel Geist, Nathalle Silvestre, Philippe Erbs
-
Publication number: 20070110713Abstract: The present invention relates to a novel fusion protein with the formula X—Y, or Y—X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.Type: ApplicationFiled: July 20, 2004Publication date: May 17, 2007Applicant: TRANSGENE S.A.Inventor: Stephane Paul
-
Publication number: 20050221435Abstract: The invention concerns a biological material for preparing pharmaceutical compositions for treating mammals including either a nucleic acid sequence, containing at least a gene of therapeutic interest and elements expressing the gene in vivo in target cells genetically modified by one such nucleic sequence, or at least a target cell not producing antibodies naturally, genetically modified in vitro by at least one such nucleic acid sequence. The gene of therapeutic interest codes for all or part of an antibody expressed at the surface of the target cell, and such an antibody is capable of fixing itself to a polypeptide present at the surface of a cytotoxic effector cell or a T lymphocyte helper involved in the process activating such a cell.Type: ApplicationFiled: May 9, 2005Publication date: October 6, 2005Inventors: Bruce Acres, Stephane Paul
-
Publication number: 20050208074Abstract: The present invention concerns a poxviral particle having a targeted infection specificity conferred by an heterologous ligand moiety present at the surface of said poxviral particle and capable of specifically recognizing and binding to an anti-ligand molecule localized at the surface of target cells. The present invention further relates to a vector comprising a nucleotide sequence encoding a chimeric polypeptide including such an heterologous ligand moiety and all or part of a natural poxviral surface polypeptide. The present invention additionally concerns compositions comprising said poxviral particle or said vector as well as their use for therapeutic and prophylactic purposes.Type: ApplicationFiled: September 7, 2004Publication date: September 22, 2005Applicant: TRANSGENE S.A.Inventors: Jean Balloul, Stephane Paul, Michel Geist, Nathalle Silvestre, Philippe Erbs
-
Publication number: 20050063945Abstract: The present invention relates to a novel fusion protein with the formula X—Y, or Y—X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X; it also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule; it also relates to infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles; is also relates to a method for recombinantly producing such a fusion protein; and, lastly, it also relates to a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.Type: ApplicationFiled: July 21, 2004Publication date: March 24, 2005Applicant: TRANSGENE S.A.Inventor: Stephane Paul
-
Publication number: 20040142885Abstract: The invention concerns a biological organism comprising at least: (i) a nucleic acid coding for all or part of an antibody, said antibody being expressed at the surface of a host cell and capable of being fixed to a polypeptide present at the surface of a cytotoxic effector cell or of a T-helper lymphocyte and involved in the process of activating such a cell and (ii) a nucleic acid coding for all or part of a polypeptide involved in the stimulation of an immune response or in attraction to the site of expression and activation of cytotoxic effector cells or of T-helper lymphocytes, said polypeptide being selected among chemokines and co-stimulation molecules. The invention also concerns a host cell and a pharmaceutical composition containing said biological organism and their therapeutic or prophylactic uses.Type: ApplicationFiled: March 8, 2004Publication date: July 22, 2004Inventors: Stephane Paul, Etienne Regulier
-
Publication number: 20040135038Abstract: A mounting assembly (10) includes an elongate member (12) in the form of a loop to support articles such as pipes. The loop extends around the pipe and into a bracket (24) which forms a tiltable joint through end (16) of the loop (14) held in slots (34) of the bracket (24). The bracket can be secured on a threaded drop rod (44) in order to adjust the position of the elongate member and bracket (26) as required for installation of the pipe.Type: ApplicationFiled: October 20, 2003Publication date: July 15, 2004Inventors: Peter Clarence Barton, Stephan Paul Barton
-
Patent number: 5117060Abstract: Disclosed is an improved process for the preparation of ketoximes, especially ketoximes derived from branched chain ketones, wherein a ketone is reacted with a hydroxylamine salt in the presence of an alkanol, a heterogeneous base and up to about 5 weight percent, based on the weight of the ketone and alkanol, water.Type: GrantFiled: June 10, 1991Date of Patent: May 26, 1992Assignee: Eastman Kodak CompanyInventor: Jonathan S. Witzeman